Markus Goebel is a seasoned life science executive and investor with extensive experience in venture capital and corporate strategy, formerly as a Managing Director at Novartis Venture Fund. A certified MD in Oncology from Ludwig-Maximilians-Universität München, he now serves on the boards of several innovative biotech and medtech companies like OSE Immunotherapeutics and HAYA Therapeutics.
He holds an MBA with a dissertation focused on characterizing blockbuster drugs, blending his deep medical knowledge with expertise in finance and deal structures.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.